Estrogen-progesterone therapy for recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia

Area of Science:

• Gastroenterology
• Cardiology
• Endocrinology

Background:

• Gastrointestinal angiodysplasia is a common cause of obscure gastrointestinal bleeding.
• Treatment options include endoscopic and surgical interventions, which may not always be successful.
• Hormonal therapy has been explored as an alternative treatment for angiodysplastic lesions.

Observation:

• A patient with recurrent gastrointestinal bleeding due to angiodysplasia, aortic stenosis, and mitral insufficiency was treated with estrogen-progesterone.
• The patient had no history of chronic renal failure.
• Gastrointestinal bleeding resolved completely following the initiation of hormone therapy.

Findings:

• Estrogen-progesterone therapy demonstrated efficacy in halting recurrent gastrointestinal bleeding.
• The treatment was successful in a patient with comorbidities including valvular heart disease.
• This suggests a potential role for hormonal therapy in managing refractory gastrointestinal angiodysplasia.

Implications:

• Conjugated estrogen therapy should be considered for patients with recurrent gastrointestinal bleeding from angiodysplasia, especially after failure of endoscopic or surgical treatments.
• This approach may be particularly beneficial for patients with associated cardiovascular conditions.
• Further research is warranted to establish the optimal use and long-term safety of estrogen therapy for gastrointestinal angiodysplasia.